☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
fresenius kabi
Fresenius Kabi Launches Otulfi (Biosimilar, Stelara) in the US
March 3, 2025
Fresenius Kabi Reports the US FDA’s 510(k) Clearance for Adaptive Nomogram, Improving Plasma Collection Efficiency
January 29, 2025
Fresenius Kabi Reports the Reguatory Submission to the US FDA for the Aurora Xi Plasmapheresis System Software Version 2.0 with Ne...
November 22, 2024
Fresenius Kabi and Formycon Report the CHMP’s Positive Opinion of Ahzantive/Baiama/FYB203 (Biosimilar, Eylea)
November 18, 2024
Fresenius Kabi and Formycon Report the US FDA’s Approval of Otulfi (Biosimilar, Stelara)
October 1, 2024
Fresenius Reports the US FDA’s BLA Acceptance of FKS518 (Biosimilar, Denosumab)
May 28, 2024
PharmaShots Weekly Snapshots (September 30 – October 04, 2024)
October 4, 2024
Fresenius Kabi and Formycon Report the US FDA’s Approval of Otulfi (Biosimilar, Stelara)
October 1, 2024
Formycon and Fresenius Kabi Reports the EC’s Approval of Otulfi (Biosimilar, Stelara) for Serious Inflammatory Diseases
September 27, 2024
Top 20 Generic Pharma Companies of 2024
September 26, 2024
PharmaShots Weekly Snapshots (July 29 – August 02, 2024)
August 2, 2024
Insights+ Key Biosimilars Events of July 2024
August 1, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.